ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
SOURCES OF BIAS IN PATIENT-REPORTED OUTCOME (PRO) DATA COLLECTION: EVIDENCE GAPS IN THEIR IMPACT ON DATA QUALITY
Mar 18, 2026, 21:38 PM -
NOVEL PATIENT-CENTERED APPROACH TO CLINICAL TRIAL READINESS IN RARE DISEASES
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC REVIEW OF FINDINGS AND METHODS IN ECONOMIC EVALUATIONS OF DYADIC HEALTHCARE INTERVENTIONS
Mar 18, 2026, 21:38 PM -
IDENTIFYING TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN SECONDARY DATA: METHODOLOGICAL CHALLENGES, EMERGING OPPORTUNITIES, AND FUTURE DIRECTIONS
Mar 18, 2026, 21:38 PM -
A GENERATIVE AI-DRIVEN FRAMEWORK FOR FEASIBILITY ASSESSMENT OF INDIRECT TREATMENT COMPARISONS OF HEALTHCARE INTERVENTIONS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INAVOLISIB IN THE TREATMENT OF PIK3A-MUTATED, HR+/HER2-ABC LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN THE US
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AMONG PEOPLE WITH MODERATE-TO-SEVERE HEMOPHILIA A AND B IN CHINA: A RETROSPECTIVE DATABASE STUDY
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE IMPACT AND BURDEN OF MENOPAUSE ON MULTIPLE SCLEROSIS THROUGH A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
A REAL-WORLD EVIDENCE STUDY OF EPIGENOMIC SUBTYPING IN LIQUID BIOPSY-BASED LUNG CANCER COHORTS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF DPYD-GUIDED FOLFOX IN UNRESECTABLE METASTATIC COLORECTAL CANCER IN THE US: A PATIENT-LEVEL MICROSIMULATION MODEL
Mar 18, 2026, 21:38 PM -
DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR MUSCULOSKELETAL DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
OBSERVED REAL-WORLD DIAGNOSIS AND SPECIALIST VISIT PATTERNS IN NEWLY DIAGNOSED AND RELAPSING MS PATIENTS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SEMAGLUTIDE 2.4 MG COMPARED WITH RESMETIROM AND STANDARD OF CARE FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN THE U.S. USING MOST FAVORED NATION (MFN) PRICING
Mar 18, 2026, 21:38 PM -
MODELLING ASSOCIATIONS BETWEEN EXTREME POVERTY TRAJECTORIES AND POPULATION GROWTH FOR HEALTH SYSTEMS PLANNING
Mar 18, 2026, 21:38 PM -
DEMOGRAPHIC DISPARITIES IN HPV VACCINE INITIATION AMONG KENTUCKY MEDICAID BENEFICIARIES
Mar 18, 2026, 21:38 PM -
VIRTUAL REALITY AS AN ADJUNCTIVE TREATMENT TO OPIOID THERAPY IN PAIN MANAGEMENT AND IMPLICATIONS FOR ADDRESSING THE U.S. OPIOID EPIDEMIC
Mar 18, 2026, 21:38 PM -
REAL-WORLD DIAGNOSTIC DELAY, TREATMENT ACCESS, AND HEALTH SYSTEM BURDEN IN PRIMARY IMMUNODEFICIENCY/INBORN ERRORS OF IMMUNITY: EVIDENCE FROM THE UNITED STATES AND EX-US SETTINGS
Mar 18, 2026, 21:38 PM -
ACCESS TO INNOVATIVE AUTOIMMUNE THERAPIES IN LATIN AMERICA: CROSS-COUNTRY EVIDENCE TO INFORM VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
ALGORITHMIC FAIRNESS IN MACHINE LEARNING PREDICTION FOR LONG-TERM ADJUVANT ENDOCRINE THERAPY ADHERENCE AMONG BREAST CANCER SURVIVORS
Mar 18, 2026, 21:38 PM